Back to catalog
30 mg
Research grade
Metabolic
In Stock
Retatrutide
Called a "triple agonist" because it activates three hormone systems: GLP-1, GIP, and Glucagon.
$168.00
per vial (30 mg)
1
For research use only
This product is intended for qualified laboratory research and is not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Researched benefits
- Very strong weight loss (up to ~25–30% body weight in studies)
- Major appetite reduction ("food noise" reduction)
- Improved blood sugar control / insulin sensitivity
- Reduced visceral fat and liver fat
- Possible improvements in sleep apnea, joint pain, metabolic disease
Available sizes
30 mg — $201.6
20 mg — $180
How it works
- GLP-1 → reduces appetite, slows digestion, increases fullness
- GIP → improves insulin response and metabolism
- Glucagon → increases energy expenditure (burn more calories)
Related research peptides
Tirzepatide · 50 mg
In Stock
Metabolic
Tirzepatide
Dual GLP-1 / GIP receptor agonist studied for glucose control and weight regulation.
50 mgResearch grade
$168.00
MOTS-c · 40 mg
In Stock
Metabolic
MOTS-c
Mitochondrial-derived peptide involved in metabolism, energy use, and insulin sensitivity.
40 mgResearch grade
$180.00
AOD-9604 · 5 mg
In Stock
Metabolic
AOD-9604
Synthetic HGH fragment designed to target fat metabolism without other GH effects.
5 mgResearch grade
$72.00